Preclinical and clinical evaluation of 5-fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with colorectal carcinoma
Open Access
- 15 October 1995
- Vol. 76 (8) , 1330-1335
- https://doi.org/10.1002/1097-0142(19951015)76:8<1330::aid-cncr2820760806>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.Journal of Clinical Oncology, 1992
- Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicityCancer, 1990
- 5-Fluorouracil With Oral Leucovorin and Hydroxyurea and Concomitant Radiotherapy for Stage III Non-Small Cell Lung CancerCancer, 1990
- Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.Journal of Clinical Oncology, 1989
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Studies of hydroxyurea administered by continuous infusion. Toxicity, pharmacokinetics, and cell synchronizationCancer, 1980
- Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinomaCancer, 1975